(GOVI) Invesco Equal Weight 0-30 - Ratings and Ratios

Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • ISIN: US46138E1073

GOVI: U.S. Treasury, Notes, Bonds, Government Securities, Fixed Income

The Invesco Equal Weight 0-30 Years Treasury ETF (NASDAQ: GOVI) is designed to provide exposure to U.S. Treasury securities with maturities ranging from 0 to 30 years. The fund typically allocates at least 80% of its total assets to the components of its underlying index, which is constructed to represent the performance of up to 30 U.S. Treasury Notes or Bonds. These securities are selected based on their annual February maturity ladder, ensuring a diversified representation across the yield curve.

The index provider carefully compiles, maintains, and calculates the underlying index, aiming to deliver a consistent and accurate measure of the U.S. Treasury market. By tracking the February maturity ladder, the index incorporates a range of securities that mature in successive years, providing a balanced exposure to short-, intermediate-, and long-term Treasury debt. This approach allows investors to gain diversified exposure to the entire yield curve, reducing concentration risk in any single maturity segment.

From a technical perspective, GOVI has shown stable price action, with its SMA 20, SMA 50, and SMA 200 all hovering closely around its last price of 27.34. This suggests a sideways trend with minimal directional bias. The Average True Range (ATR) of 0.28 indicates low volatility, making the fund appealing to risk-averse investors seeking steady income with reduced price fluctuations.

Based on the current technical and fundamental data, GOVI is expected to maintain its stable price range in the near term. The convergence of its moving averages and low ATR suggest limited downside risk, while the funds focus on U.S. Treasuries positions it as a defensive play amid economic uncertainty. With assets under management (AUM) of $862.07 million, GOVI offers sufficient liquidity for investors seeking exposure to the U.S. Treasury market.

Additional Sources for GOVI ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

GOVI ETF Overview

Market Cap in USD 899m
Category Long Government
TER 0.15%
IPO / Inception 2007-10-11

GOVI ETF Ratings

Growth Rating -44.7
Fundamental -
Dividend Rating 71.5
Rel. Strength 4.58
Analysts -
Fair Price Momentum 25.38 USD
Fair Price DCF -

GOVI Dividends

Dividend Yield 12m 3.64%
Yield on Cost 5y 2.83%
Annual Growth 5y 20.15%
Payout Consistency 93.2%
Payout Ratio %

GOVI Growth Ratios

Growth Correlation 3m -65.9%
Growth Correlation 12m -27.8%
Growth Correlation 5y -79.3%
CAGR 5y -4.95%
CAGR/Max DD 5y -0.15
Sharpe Ratio 12m 1.02
Alpha -3.25
Beta -0.100
Volatility 10.05%
Current Volume 48.1k
Average Volume 20d 86.1k
What is the price of GOVI shares?
As of June 15, 2025, the stock is trading at USD 27.08 with a total of 48,114 shares traded.
Over the past week, the price has changed by +0.82%, over one month by +0.85%, over three months by -1.57% and over the past year by +0.23%.
Is Invesco Equal Weight 0-30 a good stock to buy?
Probably not. Based on ValueRay´s Analyses, Invesco Equal Weight 0-30 (NASDAQ:GOVI) is currently (June 2025) not a good stock to buy. It has a ValueRay Growth Rating of -44.69 and therefor a somwhat technical negative rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of GOVI is around 25.38 USD . This means that GOVI is currently overvalued and has a potential downside of -6.28%.
Is GOVI a buy, sell or hold?
Invesco Equal Weight 0-30 has no consensus analysts rating.
What are the forecasts for GOVI share price target?
According to our own proprietary Forecast Model, GOVI Invesco Equal Weight 0-30 will be worth about 27.4 in June 2026. The stock is currently trading at 27.08. This means that the stock has a potential upside of +1.26%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 27.4 1.3%